首页> 外文OA文献 >PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE

【2h】

PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE

机译：PMU19使用Natalizumab的第一线治疗可降低医疗资源使用和工作生产率的损害，并与Natalizumab延迟使用相比，重复延迟多发性硬化症（RRMS）患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
C. Acosta; E. Jones; J. Pike; A. Adeyemi; S. Liao; R. Su; K. Xiong; J. Husbands;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CLINICAL OUTCOMES WERE BETTER FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS WHO REMAINED ON NATALIZUMAB COMPARED TO THOSE WHO SWITCHED TO ORAL OR INJECTABLE THERAPIES AFTER 2 YEARS IN THE TYSABRI (R) OBSERVATIONAL PROGRAM (TOP) [J] . Butzkueven Helmut, Kappos Ludwig, Spelman Tim, Journal of Neurology, Neurosurgery and Psychiatry . 2018,第6期

机译：与在Tysabri（R）观察计划（TOP）后2年后切换到口腔或可注射疗法的人相比，临床结果更好
2. Natalizumab vs fingolimod in patients with active relapsing-remitting multiple sclerosis (RRMS): comparative MRI assessments of disease activity from reveal, a randomized, head-to-head phase 4 study [J] . S. Licata, H. Butzkueven, D. Jeffery, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期

机译：Natalizumab与Fingolimod患者有活性复发 - 延长多发性硬化症（RRMS）：来自揭示，随机的头部到头期4研究的疾病活动的比较MRI评估
3. Regional efficacy of Natalizumab treatment in relapsing-remitting Multiple Sclerosis (RRMS) (vol 86, pg e4, 2016) [J] . Doshi A., Voysey Z., Bunting E., Journal of Neurology, Neurosurgery and Psychiatry . 2016,第12期

机译：纳他珠单抗治疗复发性多发性硬化症（RRMS）的区域疗效（第86卷，第e4页，2016年）
4. Predicting Future Disease Activity and Treatment Responders for Multiple Sclerosis Patients Using a Bag-of-Lesions Brain Representation [C] . Andrew Doyle, Doina Precup, Douglas L. Arnold, International conference on medical imaging computing and computer-assisted intervention . 2017

机译：使用病变袋大脑表示法预测多发性硬化症患者的未来疾病活动和治疗反应者
5. A Double-Blind Randomized Intervention to Reduce Distress from Perceived Cognitive Impairment in Multiple Sclerosis [D] . Glusman, Morgan B. 2019

机译：一种双盲随机干预，以减少多发性硬化症中感知认知障碍的痛苦
6. Patient and treatment characteristics and safety outcomes of patients with relapsing-remitting multiple sclerosis treated with natalizumab in Greece: Results from the multicenter 5-year prospective observational study ‘TOPICS greece’ [O] . Panagiotis Karanasios, Georgios Karachalios, Rania Gourgioti, 2021

机译：在希腊纳伦之瑞治疗的患者患者的患者和治疗特征和安全结果：多中心5年前瞻性观察研究Grece的结果
7. Clinical and economic efficacy of the Natalizumab in patients with relapsing-remitting multiple sclerosis (RRMS). [O] . A.K. Almadiyeva, A.S. Zhusupova, Yu.M. Semenova, 2018

机译：Natalizumab在复发饲料多发性硬化症（RRMS）患者中的临床和经济效益。

PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE

著录项

相似文献

相关主题

期刊订阅